How much has Anduril raised?
Anduril has about $11 billion reported after 2026 round; the latest public valuation/status marker is $61 billion reported in May 2026.
- Total raised
- About $11 billion reported after 2026 round
- Disclosed rounds
- 5
- Latest round
- Series H
- Latest valuation
- $61 billion reported in May 2026
- First raised
- 2017
- Notable backer
- Thrive Capital
Anduril's funding rounds
Anduril's disclosed financing history shows capital raised for product, hiring, and market expansion.
- 2017Seed/early — UndisclosedLead/backers: Founders Fund and early investors.
- 2022Series E — $1.48 billion; $8.5 billion valuationLead/backers: Valor Equity Partners.
- 2024Series F — $1.5 billion; $14 billion valuationLead/backers: Founders Fund and Sands Capital.
- 2025Series G — $2.5 billion; $30.5 billion valuationLead/backers: Founders Fund.
- 2026Series H — $5 billion; $61 billion valuationLead/backers: Thrive Capital and Andreessen Horowitz.
Sources:Business Insider Anduril 2026 fundingFinancial Times Anduril coverage
How much has Anduril raised in total?
Anduril has about $11 billion reported after 2026 round based on public reporting. 2017: Seed/early — Undisclosed, led/backed by Founders Fund and early investors. 2022: Series E — $1.48 billion, led/backed by Valor Equity Partners ($8.5 billion valuation). 2024: Series F — $1.5 billion, led/backed by Founders Fund and Sands Capital ($14 billion valuation). 2025: Series G — $2.5 billion, led/backed by Founders Fund ($30.5 billion valuation). 2026: Series H — $5 billion, led/backed by Thrive Capital and Andreessen Horowitz ($61 billion valuation).
Where debt, secondaries, or preferred-equity packages are included in public reporting, they are described as reported rather than converted into common-equity funding.
Who are Anduril's investors?
The disclosed investor base includes Founders Fund and early investors; Valor Equity Partners; Founders Fund and Sands Capital; Founders Fund. These investors matter because they indicate whether the company is optimized for venture-scale software growth, capital-intensive deployment, clinical development, or government procurement.
For sellers, investor quality is a useful signal, but procurement timing still depends on budget ownership and integration urgency.
Why did Anduril's valuation move?
The latest public marker is $61 billion reported in May 2026. Valuation movement appears tied to progress in defense technology, public customer/partner proof, and the broader investor appetite for AI-enabled category leaders.
No public source confirms profitability, so valuation should be treated as a financing-market signal rather than an operating-margin signal.
Is Anduril profitable, and will it IPO?
Anduril has not publicly disclosed audited profitability. IPO timing is not confirmed unless explicitly stated in company or news sources.
The practical read is that the company remains private and is using capital to extend product, hiring, regulatory, deployment, or R&D capacity.
What does Anduril's funding mean if you sell into them?
The funding profile suggests budget exists for tools tied directly to defense technology, security, compliance, infrastructure, hiring leverage, and customer deployment. Sellers should map pitches to a funded initiative rather than a generic productivity story.
The best outreach angle is to show how a product shortens deployment time, lowers risk, or improves measurable outcomes for the teams named in the leadership and product sections.
As of June 2026.Sources:Anduril websiteBusiness Insider Anduril 2026 fundingFinancial Times Anduril coverage
Anduril — frequently asked questions
